ArticleTranslational cancer research2023

Acquired BRAF gene fusions in Osimertinib resistant EGFR-mutant non-small cell lung cancer.

Rafael Rosell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.